1. Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol. Issue 11 (November 1991) Authors: Playford, R J; Batten, J J; Freeman, T C; Beardshall, K; Vesey, D A; Fenn, G C; Baron, J H; Calam, J Journal: Gut Issue: Volume 32:Issue 11(1991) Page Start: 1396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Laser microdissection expression profiling of marginal edges of colorectal tumours reveals evidence of increased lactate metabolism in the aggressive phenotype. Issue 3 (31st October 2008) Authors: Thorn, C C; Freeman, T C; Scott, N; Guillou, P J; Jayne, D G Journal: Gut Issue: Volume 58:Issue 3(2009) Page Start: 404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P390 Ustekinumab modulates IL-12 and IL-23-related cell type-specific inflammatory transcriptional states in Ulcerative Colitis induction therapy. (30th January 2023) Authors: Richards, D; Venkat, S; Freeman, T C; Mcrae, B; Hoops, T; Marano, C; Branigan, P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice. Issue 11 (November 1990) Authors: Freeman, T C; Playford, R J; Quinn, C; Beardshall, K; Poulter, L; Young, J; Calam, J Journal: Gut Issue: Volume 31:Issue 11(1990) Page Start: 1318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗